Lumenis is a technology company.
Key people at Lumenis.
Lumenis was founded in 1966 by Shimon Eckhouse (Founder, chairman and CEO).
Key people at Lumenis.
Lumenis is a global leader in minimally invasive clinical solutions for surgical, ophthalmic, and aesthetic markets, specializing in energy-based technologies like lasers, intense pulsed light (IPL), and radio-frequency (RF) systems.[1][2][3] It develops products for medically necessary treatments (e.g., glaucoma, retinal conditions) and elective procedures, serving clinics and hospitals worldwide with an installed base exceeding 80,000 systems across over 100 countries.[1][2][3] The company solves critical healthcare challenges by enabling precise, non-invasive therapies—such as Selective Laser Trabeculoplasty (SLT) for glaucoma with a 93% success rate—and drives growth through over 270 patents, 100+ FDA clearances, and partnerships with key opinion leaders (KOLs).[1][2]
Founded in 1966, Lumenis pioneered laser-based medical treatments, becoming the first company to commercially introduce a laser product for retinal conditions.[1][2] Its early innovations included solutions for anterior and posterior eye segments, addressing issues like diabetic retinopathy, retinal detachment, glaucoma, and secondary cataracts.[1] By 1991, it had established a strong global presence, evolving over nearly 60 years to set technological gold standards in ophthalmology, surgery, and aesthetics through continuous R&D and expansions like the Array LaserLink for efficient retinal pattern scanning.[1][2][3]
Lumenis rides the wave of advancing minimally invasive medical technologies, capitalizing on rising demand for precise, outpatient energy-based treatments amid aging populations and chronic eye diseases like glaucoma and diabetic retinopathy.[1] Its timing aligns with healthcare shifts toward non-surgical options, fueled by market forces such as expanding aesthetic procedures and regulatory approvals (e.g., FDA clearances).[2] By influencing standards—through innovations like SLT and pattern scanning lasers—Lumenis shapes ophthalmology and aesthetics ecosystems, enabling faster procedures and better outcomes that reduce hospital burdens globally.[1][2]
Lumenis is poised for sustained growth by leveraging its patent portfolio and global footprint to expand into emerging ophthalmic diagnostics and next-gen RF/IPL hybrids.[1][2] Trends like AI-enhanced laser precision and personalized medicine will amplify its edge, potentially boosting adoption in underserved markets. Its influence may evolve toward dominating integrated eye care platforms, reinforcing its legacy as a trailblazer in energy-based clinical innovation.[1][3]
Lumenis was founded in 1966 by Shimon Eckhouse (Founder, chairman and CEO).
